F
Frontier Derm Partners | Mill Creek, WA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Apremilast
BMS-986165
Deucravacitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 1...
Active, not recruiting
Plaque Psoriasis
Drug: Apremilast
The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with modera...
Enrolling
Plaque Psoriasis
Drug: Deucravacitinib
Other: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems